CDC6 as a pan-cancer immunological and prognostic biomarker and its role in suppressing melanoma malignancy
Abstract Background: Cell division cycle 6 (CDC6) is a key licensing factor for DNA replication in the G1 and S…
Lijun Mo
MYCBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients
Abstract Introduction: Immune checkpoint inhibitors (ICIs) have shown promising results for the treatment of multiple cancers. ICIs and related therapies…